Cargando…
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Lung cancer shows substantial genetic and phenotypic heterogeneity across individuals, driving a need for personalised medicine. Here, we report lung cancer organoids and normal bronchial organoids established from patient tissues comprising five histological subtypes of lung cancer and non-neoplast...
Autores principales: | Kim, Minsuh, Mun, Hyemin, Sung, Chang Oak, Cho, Eun Jeong, Jeon, Hye-Joon, Chun, Sung-Min, Jung, Da Jung, Shin, Tae Hoon, Jeong, Gi Seok, Kim, Dong Kwan, Choi, Eun Kyung, Jeong, Seong-Yun, Taylor, Alison M., Jain, Sejal, Meyerson, Matthew, Jang, Se Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728380/ https://www.ncbi.nlm.nih.gov/pubmed/31488816 http://dx.doi.org/10.1038/s41467-019-11867-6 |
Ejemplares similares
-
Data on the evaluation of the relation between β-arrestin 2 and YAP phosphorylation in patient-derived colon cancer organoids
por: Kim, Minsuh, et al.
Publicado: (2022) -
Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival
por: Cho, Eun Jeong, et al.
Publicado: (2021) -
β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity
por: Kim, Minsuh, et al.
Publicado: (2022) -
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids
por: Park, Dongil, et al.
Publicado: (2023) -
Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)
por: Lee, Sang-Yun, et al.
Publicado: (2023)